相关实验视频
Updated: May 12, 2026

08:09
A Doxorubicin-induced Cardiomyopathy Model in Adult Zebrafish
Published on: June 7, 2018
9.8K
辅酶Q10对多克索鲁比诱导心脏毒性的保护作用:范围审查文章
Al Qahtani Abdullah1,2, Al Balawi Hamed1,3, Al Jowesim Fahad1,2
1King Faisal University, Collage of Clinical Pharmacy, Alahsa, Saudi Arabia.
概括
辅酶Q10显示出对多克索鲁比诱导的心脏毒性的心脏保护作用. 这种抗氧化剂可能有助于预防在接受多克索鲁比辛治疗的癌症患者的心脏损伤.
科学领域:
- 药理学 药理学 是一个学科.
- 心脏病学 心脏病学
- 在瘤学瘤学.
背景情况:
- 多克索鲁比 (阿德里亚米) 是一种用于癌症治疗的抗生素.
- 德克索鲁比可以引起急性心脏毒性,原因是自由基的释放和脂质过氧化.
- 辅酶Q10是一种细胞抗氧化剂,可以对抗氧化应激和脂质过氧化.
研究的目的:
- 在动物模型中评估辅酶Q10对多克索鲁比诱导心脏毒性的心脏保护潜力.
主要方法:
- 根据Arksey和O'Malley的方法来进行范围审查.
- 搜索了1978年10月至2023年9月发表的文章.
- 包含了来自11,303.3的初始搜索中的14篇文章.
主要成果:
- 在14篇审查的文章中,有10篇表明辅酶Q10具有保护作用.
- 在动物研究中,辅酶Q10在减轻多克索鲁比诱导的心脏毒性方面表现出有效性.
结论:
- 辅酶Q10表现出对多克索鲁比诱导的心脏毒性的保护作用.
- 辅酶Q10是一种潜在的治疗补充剂,用于预防用多克索鲁比治疗的癌症患者的心脏毒性.
相关概念视频
Electron Transport Chain: Complex I and II
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
Drug Toxicity: Overview
Drug toxicity quantifies the harm a compound causes to an organism, varying by dose and potentially impacting whole systems or specific organs like the liver. Toxic reactions may arise from venomous insect or spider bites, with effects ranging from mild symptoms to severe outcomes such as brain damage or death. Common forms of acute poisoning include ethanol intoxication and overdose of pain or fever medications, with substances like GHB and heroin being particularly lethal at doses close to...
Drug Toxicity: Risk factors
Adverse Drug Reactions (ADRs) are potential complications that arise during pharmacotherapy, influenced by multiple risk factors. Age plays a significant role; both neonates and the elderly are at heightened risk due to their respective immature and diminished metabolic and elimination processes. Gender also impacts ADRs, with females experiencing a 1.5 to 1.7-fold greater risk than males, which may be linked to pharmacokinetic, pharmacodynamic, and hormonal differences. Notably, neonates, the...
Drug Toxicity: Dose-Dependent Reactions
Drug toxicities can be stratified into pharmacological, pathological, or genotoxic based on their mechanisms. The incidence and severity of these toxicities generally increase with the drug's concentration in the body and exposure time.Pharmacological toxicity is evident when the therapeutic effects of drugs overshoot into adverse reactions in a predictable, dose-dependent manner. Central nervous system (CNS) depression from barbiturates is a classic example, with effects escalating from...
Cardiopulmonary Resuscitation IV: Pharmacological Management
Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
Cardiomyopathy IV: Restrictive Cardiomyopathy
Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...

